Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 6/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.35 |
| ▸ | SNCA | P37840 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | APEX1 | P27695 | 3/20 | 0.35 |
| ▸ | RECQL | P46063 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | RAD52 | P43351 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30392289 | 1.00 | MAOA (0.37) | MAOAMAOBBACE1KDM4EALDH1A1 | |
| SCHEMBL15628793 | 0.82 | ALDH1A1 (0.32) | MAOAMAOBALDH1A1HPGDNPSR1 | |
| SCHEMBL14390906 | 0.81 | ALOX15 (0.38) | ALOX15MAPTHPGDMEN1KMT2A | |
| SCHEMBL10033616 | 0.81 | FFAR4 (0.37) | MAOAMAOBALDH1A1MAPTHPGD | |
| SCHEMBL21500712 | 0.78 | ALOX5 (0.31) | RAB9ANPC1 | |
| SCHEMBL26159938 | 0.78 | TDP1 (0.34) | MAOAMAOBKDM4EALDH1A1HSD17B10 | |
| SCHEMBL26042290 | 0.78 | MAOA (0.37) | MAOAMAOBPTGS2MTNR1AMTNR1B | |
| SCHEMBL14541022 | 0.78 | PGR (0.46) | KDM4EALDH1A1MAPTHPGDMEN1 | |
| SCHEMBL21500751 | 0.77 | SMN1; SMN2 (0.32) | MAOAMAOBRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL18809447 | 0.77 | HSP90AA1 (0.32) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115708882-A | Nano-particle, preparation method thereof and application thereof in preparing medicine for treating myocardial infarction | 浙江大学 | 2023-02-24 | — | — | CN | claimed |
| CN-115708882-B | Nanoparticle, preparation method thereof and application thereof in preparation of medicines for treating myocardial infarction | 浙江大学 | 2024-02-20 | — | — | CN | disclosed |
| WO-2023117847-A1 | USE OF CATECHIN FOR THE TREATMENT OF FGFR-RELATED BONE REPAIR AND BONE FORMATION IMPAIRMENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023111165-A1 | COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICITS WITH A CATECHIN | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023069529-A1 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | AKIRABIO, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| US-11596662-B2 | Passion flower seed extract, and cosmetic, pharmaceutical or dermatological compositions containing same | LABORATOIRES EXPANSCIENCE (FR) | 2023-03-07 | — | — | US | disclosed |
| CN-115708882-A | Nano-particle, preparation method thereof and application thereof in preparing medicine for treating myocardial infarction | 浙江大学 | 2023-02-24 | — | — | CN | disclosed |
| WO-2023288020-A1 | COMPOSITIONS AND METHODS FOR ANTIOXIDANT AND ANTI-INFLAMMATORY THERAPEUTICS | AVANTI BIOSCIENCES INC. (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2021263072-A1 | METHODS OF TREATING DISEASE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2021-12-30 | — | — | WO | disclosed |
| EP-2948437-B1 | APPROACH FOR SYNTHESIS OF CATECHINS | EPIRIUM BIO INC (US) | 2021-11-03 | — | — | EP | disclosed |
| EP-2668176-B1 | A NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | SPHAERA PHARMA PTE LTD (SG) | 2017-05-17 | — | — | EP | disclosed |
| EP-2330104-B1 | GLUCOSYLTRANSFERASE INHIBITOR CONTAINING EPIGALLOCATECHIN GALLATE POLYMER AS ACTIVE INGREDIENT | SUNTORY HOLDINGS LTD (JP) | 2017-03-01 | — | — | EP | disclosed |
| EP-2948128-B1 | SKIN CARE COMPOSITION | UNILEVER NV (NL) | 2016-10-05 | — | — | EP | disclosed |
| US-20160058813-A1 | Pea (Pisum sativum L.) Seed Coats and Seed Coat Fractions | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2016-03-03 | — | — | US | disclosed |
| US-20140228306-A1 | Phenolic Coatings and Methods of Making and Using Same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-08-14 | — | — | US | disclosed |
| WO-2014114496-A2 | SKIN CARE COMPOSITION | UNILEVER N.V. (NL) | 2014-07-31 | — | — | WO | disclosed |
| US-20140206630-A1 | Phenolic Coatings and Methods of Making and Using Same | NORTHWESTERN UNIVERSITY | 2014-07-24 | — | — | US | disclosed |
| EP-2433625-A1 | ANTI-OBESITY AGENT COMPRISING COMPOUND CONTAINING BENZOTROPOLONE RING | Suntory Holdings Limited (JP) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010097643-A1 | FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE | NOVATECH ISTRAZIVANJE D.O.O. (HR) | 2010-09-02 | — | — | WO | disclosed |
| US-20100028278-A1 | USE OF CHROMAN-4-ONE DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11596662-B2 | Passion flower seed extract, and cosmetic, pharmaceutical or dermatological compositions containing same | CUTA, PGA5, TYR | MAOA 478/4885MAOB 1384/4885BACE1 3794/4885 |
| US-20100028278-A1 | USE OF CHROMAN-4-ONE DERIVATIVES | COXFA4L2, TYR, XPA | MAOA 310/4885MAOB 876/4885BACE1 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.